|
RICHMOND, VA – April 12, 2023– The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it is accepting letters of intent (LOI) for Grant Round 15 to fund the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy.
“When you combine world class research with entrepreneurial management and capital, then stir, good things happen,” said Mike Grisham, CEO of Virginia Catalyst. “We are looking for passionate research scientists and entrepreneurial leaders in high-growth life science businesses in Virginia who could use $200,000 to $800,000 in non-dilutive grant funding to further a project that improves human health and advances economic development in the Commonwealth. Our Grant Round 15 is now open, and we strongly encourage interested parties to visit the Virginia Catalyst website and apply.” Letters of Intent (LOI) must be received by June 20, 2023 at 5:00 PM EDT. Projects that meet funding criteria will be invited to submit a full application. Applications will be reviewed and scored by an independent review team of scientists, venture capitalists and CEOs of Virginia-based life science companies. The top eight applicant teams will be invited to present their proposal the week of September 25, 2023. Awards will be announced at the end of September 2023. The LOI submission form, along with funding criteria and frequently asked questions, are available on the Virginia Catalyst website (www.virginiacatalyst.org/apply.html). Read the full press release
0 Comments
|
RSS Feed
